Literature DB >> 20632147

Ankylosing spondylitis.

Jeanette Wolf1, Peter Fasching.   

Abstract

Ankylosing Spondylitis (AS) is an autoimmune disease of unknown cause belonging to the group of spondyloarthritides associated with HLA B27. This disease affects the spine and sacroiliac joints, but may also concern peripheral joints and different organs. Symptoms include morning stiffness and dull low back pain, both improving by exercise. AS causes reduction in life expectancy due to subsequent manifestation in different organs, so early diagnosis and treatment are of great importance.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20632147     DOI： 10.1007/s10354-010-0793-2

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


  5 in total

Review 1.  Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome.

Authors:  J M Moll; I Haslock; I F Macrae; V Wright
Journal:  Medicine (Baltimore)       Date:  1974-09       Impact factor: 1.889

2.  Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group.

Authors:  D van der Heijde; N Bellamy; A Calin; M Dougados; M A Khan; S van der Linden
Journal:  J Rheumatol       Date:  1997-11       Impact factor: 4.666

3.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

4.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

5.  A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.

Authors:  S Garrett; T Jenkinson; L G Kennedy; H Whitelock; P Gaisford; A Calin
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666
  5 in total
  4 in total

1.  [Seronegative spondylarthritis].

Authors:  Peter Fasching
Journal:  Wien Med Wochenschr       Date:  2010-05

2.  The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line.

Authors:  Fahimeh Jafarnezhad-Ansariha; Mir Saeed Yekaninejad; Ahmad-Reza Jamshidi; Reza Mansouri; Mahdi Vojdanian; Mahdi Mahmoudi; Mohammad Javad Fattahi; Seyed Naser Hashemi; Bernd H A Rehm; Hidenori Matsuo; Emanuela Esposito; Salvatore Cuzzocrea; Abbas Mirshafiey
Journal:  Inflammopharmacology       Date:  2017-08-17       Impact factor: 4.473

3.  Increased occurrence of spinal fractures related to ankylosing spondylitis: a prospective 22-year cohort study in 17,764 patients from a national registry in Sweden.

Authors:  Yohan Robinson; Bengt Sandén; Claes Olerud
Journal:  Patient Saf Surg       Date:  2013-01-07

4.  Bioinformatics Analysis of the Molecular Mechanism and Potential Treatment Target of Ankylosing Spondylitis.

Authors:  Fanyan Meng; Ningna Du; Daoming Xu; Li Kuai; Lanying Liu; Minning Xiu
Journal:  Comput Math Methods Med       Date:  2021-07-21       Impact factor: 2.238
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.